Home › Funds › MAVERICK CAPITAL LTD › BSX

MAVERICK CAPITAL LTD position in BSX

BOSTON SCIENTIFIC CORP · Health Care

MAVERICK CAPITAL LTD reported holding 5,937,553 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$253.4M, representing 2.36% of its reported portfolio and ranking #18 among its reported holdings. MAVERICK CAPITAL LTD has disclosed BSX holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)5.94M sh
Reported value held$253.41M
Portfolio Weight2.36%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MAVERICK CAPITAL LTD's BSX position evolved

MAVERICK CAPITAL LTD first disclosed a stake in BSX in Q4 2023 at 8,831 shares (US$511K). The position peaked in Q4 2025 at 2,944,254 shares, worth US$280.7M. Across 5 filings, MAVERICK CAPITAL LTD increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,937,553 shares valued at US$253.4M — an increase of 4,937,553 shares quarter over quarter.. Notable position changes include a 35% trim in Q1 2024 (shares rose 12% over the following quarter), a 66% trim in Q1 2026 (shares fell 32% over the following quarter), a 494% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 8.83K $510.52K New
Q1 2024 5.75K $393.68K Reduce
Q4 2025 2.94M $280.73M New
Q1 2026 1.00M $62.75M Reduce
Q2 2026 5.94M $253.41M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has MAVERICK CAPITAL LTD held BSX?

MAVERICK CAPITAL LTD has disclosed BSX holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

What is MAVERICK CAPITAL LTD's current position in BSX?

As of Q2 2026, MAVERICK CAPITAL LTD holds 5.94M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $253.41M, representing 2.36% of its reported portfolio and ranking #18.

Has MAVERICK CAPITAL LTD been buying or selling BSX?

In the latest 13F filing (Q2 2026), MAVERICK CAPITAL LTD increased its position in BSX. The position peaked in Q4 2025 at 2.94M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.